Howard Liang

2018

In 2018, Howard Liang earned a total compensation of $3.9M as Chief Financial Officer and Chief Strategy Officer at BeiGene, Ltd., a 9% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$278,375
Option Awards$2,583,182
Salary$425,000
Stock Awards$645,770
Other$8,250
Total$3,940,577

Liang received $2.6M in option awards, accounting for 66% of the total pay in 2018.

Liang also received $278.4K in non-equity incentive plan, $425K in salary, $645.8K in stock awards and $8.3K in other compensation.

Rankings

In 2018, Howard Liang's compensation ranked 2,838th out of 14,244 executives tracked by ExecPay. In other words, Liang earned more than 80.1% of executives.

ClassificationRankingPercentile
All
2,838
out of 14,244
80th
Division
Manufacturing
1,048
out of 5,765
82nd
Major group
Chemicals And Allied Products
360
out of 2,128
83rd
Industry group
Drugs
295
out of 1,817
84th
Industry
Pharmaceutical Preparations
226
out of 1,391
84th
Source: SEC filing on April 29, 2019.

Liang's colleagues

We found five more compensation records of executives who worked with Howard Liang at BeiGene, Ltd. in 2018.

2018

John Oyler

BeiGene, Ltd.

Chief Executive Officer

2018

Xiaobin Wu

BeiGene, Ltd.

General Manager of China and President

2018

Jane Huang

BeiGene, Ltd.

Chief Medical Officer

2018

Amy Peterson

BeiGene, Ltd.

Chief Medical Officer

2018

Hematology Peterson

BeiGene, Ltd.

Chief Medical Officer

News

In-depth

You may also like